Prevalence and determinants of controlled hypertension in a German population cohort

BMC Public Health

Volumn 13, Issue 1, 2013, Pages

  Van Den Berg, Neeltje ^a   Meinke Franze, Claudia ^a   Fiss, Thomas ^b   Baumeister, Sebastian E ^a   Hoffmann, Wolfgang ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Antihypertensive treatment; Determinants of normotensive blood pressure; Hypertension; Study of Health in Pomerania (SHIP)

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMORBIDITY; COMPLICATION; DRUG EFFECTS; ETHNIC GROUP; FEMALE; GERMANY; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; STATISTICAL MODEL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COHORT STUDIES; COMORBIDITY; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; FEMALE; GERMANY; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; STROKE;

EID: 84879059664     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-594     Document Type: Article

References (20)

1. Regional disparities of hypertension prevalence and management within Germany. Meisinger C, Heier M, Völzke H, Löwel H, Mitusch R, Hense HW, Lüdemann J, J Hypertens 2006 24 2 293 299 10.1097/01.hjh.0000200508.10324. 8e 16508575 (Pubitemid 43348240)
2. Epidemiology of hypertension in Germany. Selected results of population-representative cross-sectional studies. Löwel H, Meisinger C, Heier M, Hymer H, Alte D, Völzke H, Dtsch Med Wochenschr 2006 131 46 2586 2591 10.1055/s-2006-956253 17096304 (Pubitemid 44899498)
3. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodríguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F, JAMA 2003 289 18 2363 2369 10.1001/jama.289.18.2363 12746359 (Pubitemid 37430168)
4. Global burden of hypertension: analysis of worldwide data. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J, Lancet 2005 365 217 223 15652604 (Pubitemid 40138015)
5. Janhsen K, Strube H, Starker A, Gesundheitsberichterstattung des Bundes-Heft 43: Hypertonie Berlin: Oktoberdruck AG 2008
6. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology, et al. J Hypertens 2007 25 6 1105 1187 10.1097/HJH.0b013e3281fc975a 17563527 (Pubitemid 46924065)
7. German Hypertension Society, Leitlinien zur Behandlung der arteriellen Hypertonie http://www.awmf.org/leitlinien/detail/ll/046-001.html (accessed 21 July 2011)
8. Reappraisal of European guidelines on hypertension management: a European society of hypertension task force document. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, Cifkova R, Clément D, Coca A, Dominiczak A, Erdine S, Fagard R, Farsang C, Grassi G, Haller H, Heagerty A, Kjeldsen SE, Kiowski W, Mallion JM, Manolis A, Narkiewicz K, Nilsson P, Olsen MH, Rahn KH, Redon J, Rodicio J, Ruilope L, Schmieder RE, Struijker-Boudier HA, van Zwieten PA, European Society of Hypertension, et al. J Hypertens 2009 27 11 2121 2158 10.1097/HJH.0b013e328333146d 19838131
9. German Hypertension Society, Neue Entwicklungen in der Hochdrucktherapie: eine Bewertung durch die Deutsche Hochdruckliga e.V. DHL, Deutsche Gesellschaft für Hypertonie und Prävention [ http://www.awmf.org/leitlinien/ detail/ll/046-001.html ] (accessed 24th July 2012)
10. Differential hypertensive therapy according to the guidelines. Rahn KH, Internist 2009 50 433 441 10.1007/s00108-008-2292-8 19305959
11. Study of Health In Pomerania (SHIP): a health examination survey in an east German region: objectives and design. John U, Greiner B, Hensel E, Lüdemann J, Piek M, Sauer S, Adam C, Born G, Alte D, Greiser E, Haertel U, Hense HW, Haerting J, Willich S, Kessler C, Soz Praventivmed 2001 46 3 186 194 10.1007/BF01324255 11565448 (Pubitemid 32747278)
12. Cohort profile: the study of health in Pomerania. Völzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, Aumann N, Lau K, Piontek M, Born G, Havemann C, Ittermann T, Schipf S, Haring R, Baumeister SE, Wallaschofski H, Nauck M, Frick S, Arnold A, Jünger M, Mayerle J, Kraft M, Lerch MM, Dörr M, Reffelmann T, Empen K, Felix SB, Obst A, Koch B, Gläser S, et al. Int J Epidemiol 2011 40 2 294 307 10.1093/ije/dyp394 20167617
13. Anatomisch-therapeutisch-chemische Klassifikation mit Tagesdosen, Amtliche Fassung des ATC-Index mit DDD-Angaben für Deutschland im Jahr 2006 Köln: DIMDI 2008
14. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. 7.Guidelines Sub-Committee, J Hypertens 1999 17 151 183 10067786
15. Detection of drug related problems in an interdisciplinary health care model for rural areas in Germany. Fiss T, Ritter CA, Alte D, van den Berg N, Hoffmann W, Pharm World Sci 2010 32 5 566 574 10.1007/s11096-010-9409-6 20593238
16. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. McAlister FA, Wilkins K, Joffres M, Leenen FH, Fodor G, Gee M, Tremblay MS, Walker R, Johansen H, Campbell N, CMAJ 2011 183 9 1007 1013 10.1503/cmaj.101767 21576297
17. Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study. Erkens JA, Panneman MM, Klungel OH, van den Boom G, Prescott MF, Herings RM, Pharmacoepidemiol Drug Saf 2005 14 11 795 803 10.1002/pds.1156 16178043 (Pubitemid 41684472)
18. Barriers to adherence and hypertension control in a racially diverse representative sample of elderly primary care patients. Turner BJ, Hollenbeak C, Weiner MG, Ten Have T, Roberts C, Pharmacoepidemiol Drug Saf 2009 18 8 672 681 10.1002/pds.1766 19479901
19. Barriers to hypertension control. Borzecki AM, Oliveria SA, Berlowitz DR, Am Heart J 2005 149 5 785 794 10.1016/j.ahj.2005.01.047 15894958 (Pubitemid 40718872)
20. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Schaefer M, Pharm World Sci 2002 24 4 120 127 10.1023/A:1019543029936 12227243 (Pubitemid 34951309)